Cerebral hemorrhage
Conditions
Interventions
Experimental observation group: Esmolol (Recommended dose: Load dose of 0.5mg/kg, followed by intravenous infusion at 0.05mg/kg/min, blood pressure monitoring, observation and Recommended usage and do
Sponsors
Shandong University Qilu Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with spontaneous cerebral hemorrhage according to the Chinese Guidelines for Diagnosis and Treatment of Cerebral Hemorrhage 2019 (i.e. (1) acute onset; (2) Symptoms of functional impairment of the Vesta channel (a few are comprehensive neurological impairment), often accompanied by headache, vomiting, elevated blood pressure and varying degrees of consciousness disorders; (3) Head CT or MRI showing bleeding focus; (4) Non-vascular cerebral causes were excluded. Satisfy the above 4, can be diagnosed as spontaneous cerebral hemorrhage); 2. Age =18 years old, gender unlimited; 3. Patients with blood pressure =140/90mmHg upon arrival at hospital.
Exclusion criteria
Exclusion criteria: 1. Secondary cerebral hemorrhage caused by vascular disease, tumor stroke, etc.; 2. Heart rate below 60bpm; 3. Patients with bronchial asthma or history of asthma and severe COPD; 4. Patients with sluggish antrum and second to third degree atrioventricular block; 5. Cardiac insufficiency or cardiogenic shock; 6. Researchers believe that they cannot be included in the study for other reasons; 7. I refuse to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate; | — |
Countries
China
Contacts
Public ContactQibin Huang
Shandong University Qilu Hospital
Outcome results
None listed